Zhejiang Yatai Pharmaceutical Co Ltd (002370) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang Yatai Pharmaceutical Co Ltd (002370) has a cash flow conversion efficiency ratio of -0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-6.29 Million ≈ $-920.75K USD) by net assets (CN¥1.12 Billion ≈ $164.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Zhejiang Yatai Pharmaceutical Co Ltd's balance sheet to measure how much of total assets are equity-financed.
Zhejiang Yatai Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how Zhejiang Yatai Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Zhejiang Yatai Pharmaceutical Co Ltd (002370) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Zhejiang Yatai Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Yatai Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vaalco Energy Inc
NYSE:EGY
|
-0.114x |
|
Sharda Motor Industries Limited
NSE:SHARDAMOTR
|
0.127x |
|
MapLight Therapeutics, Inc. Common Stock
NASDAQ:MPLT
|
-0.102x |
|
Beijing Jiaxun Feihong Electrical Co Ltd
SHE:300213
|
0.032x |
|
Huamei Holding
SHE:000607
|
0.037x |
|
Guangzhou Grandbuy Co Ltd
SHE:002187
|
0.021x |
|
Laurent-Perrier
PA:LPE
|
0.002x |
|
Tekla Life Sciences Investors
NYSE:HQL
|
-0.002x |
Annual Cash Flow Conversion Efficiency for Zhejiang Yatai Pharmaceutical Co Ltd (2007–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang Yatai Pharmaceutical Co Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see 002370 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.12 Billion ≈ $163.93 Million |
CN¥28.90 Million ≈ $4.23 Million |
0.026x | +2.97% |
| 2024-12-31 | CN¥972.18 Million ≈ $142.26 Million |
CN¥24.35 Million ≈ $3.56 Million |
0.025x | -0.69% |
| 2023-12-31 | CN¥580.87 Million ≈ $85.00 Million |
CN¥14.65 Million ≈ $2.14 Million |
0.025x | -36.90% |
| 2022-12-31 | CN¥301.22 Million ≈ $44.08 Million |
CN¥12.04 Million ≈ $1.76 Million |
0.040x | +550.26% |
| 2021-12-31 | CN¥432.96 Million ≈ $63.36 Million |
CN¥-3.84 Million ≈ $-562.46K |
-0.009x | -132.93% |
| 2020-12-31 | CN¥660.41 Million ≈ $96.64 Million |
CN¥17.81 Million ≈ $2.61 Million |
0.027x | +130.62% |
| 2019-12-31 | CN¥633.06 Million ≈ $92.64 Million |
CN¥-55.74 Million ≈ $-8.16 Million |
-0.088x | -665.50% |
| 2018-12-31 | CN¥2.38 Billion ≈ $347.71 Million |
CN¥36.99 Million ≈ $5.41 Million |
0.016x | -72.20% |
| 2017-12-31 | CN¥2.28 Billion ≈ $333.36 Million |
CN¥127.59 Million ≈ $18.67 Million |
0.056x | +418.91% |
| 2016-12-31 | CN¥2.17 Billion ≈ $317.02 Million |
CN¥-38.05 Million ≈ $-5.57 Million |
-0.018x | -113.80% |
| 2015-12-31 | CN¥793.15 Million ≈ $116.06 Million |
CN¥100.93 Million ≈ $14.77 Million |
0.127x | +29.72% |
| 2014-12-31 | CN¥747.31 Million ≈ $109.36 Million |
CN¥73.31 Million ≈ $10.73 Million |
0.098x | +123.74% |
| 2013-12-31 | CN¥709.83 Million ≈ $103.87 Million |
CN¥31.12 Million ≈ $4.55 Million |
0.044x | +393.75% |
| 2012-12-31 | CN¥703.94 Million ≈ $103.01 Million |
CN¥-10.51 Million ≈ $-1.54 Million |
-0.015x | -122.80% |
| 2011-12-31 | CN¥745.30 Million ≈ $109.06 Million |
CN¥48.79 Million ≈ $7.14 Million |
0.065x | +1354.02% |
| 2010-12-31 | CN¥719.95 Million ≈ $105.35 Million |
CN¥-3.76 Million ≈ $-549.96K |
-0.005x | -101.76% |
| 2009-12-31 | CN¥229.79 Million ≈ $33.63 Million |
CN¥68.26 Million ≈ $9.99 Million |
0.297x | +603.47% |
| 2008-12-31 | CN¥198.69 Million ≈ $29.07 Million |
CN¥-11.72 Million ≈ $-1.72 Million |
-0.059x | -140.37% |
| 2007-12-31 | CN¥157.93 Million ≈ $23.11 Million |
CN¥23.08 Million ≈ $3.38 Million |
0.146x | -- |
About Zhejiang Yatai Pharmaceutical Co Ltd
Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. The company offers solid dosage, cephalosporin powder injection, and freeze-dried powder injection products. It also provides various antibiotic and non-antibiotic drugs. The company was founded in 1989 and is based in Shaoxing, China.